汇宇制药(688553.SH)：西咪替丁注射液获得药品注册证书

Core Viewpoint - The company Huayu Pharmaceutical (688553.SH) has received approval from the National Medical Products Administration for its product, Cimetidine Injection, which is primarily indicated for gastrointestinal ulcers [1] Group 1: Product Approval - The Cimetidine Injection has been classified as a Class 3 chemical drug, approved based on the technical requirements for consistency in quality and efficacy with reference formulations [1] - The approval signifies that the product has passed the consistency evaluation for generic drugs, enhancing the company's competitive edge [1] Group 2: Market Implications - According to national policies, drugs that pass the consistency evaluation will receive greater support in areas such as medical insurance payments and procurement by medical institutions [1] - The successful development and approval of Cimetidine Injection are expected to positively impact the company's growth [1]